Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph Corey

Showing results (61-70 of 154) with videos related to

Pageof 16
Sort By:
Antimicrobial Agents and Chemotherapy|March 10, 2010
Determination of an inoculum effect with various cephalosporins among clinical isolates of methicillin-susceptible Staphylococcus aureusEsteban C Nannini, Martin E Stryjewski, Kavindra V Singh, et al.
Perioperative Medicine (London, England)|June 18, 2016
A randomized, double-blind, placebo controlled safety, tolerability, and pharmacokinetic dose escalation study of a gentamicin vancomycin gel in patients undergoing colorectal surgeryElliott Bennett-Guerrero, Harold S Minkowitz, Alvaro M Segura-Vasi, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|February 6, 2007
Correlation between fundamental binding forces and clinical prognosis of Staphylococcus aureus infections of medical implantsRuchirej Yongsunthon, Vance G Fowler, Brian H Lower, et al.
Current Infectious Disease Reports|July 10, 2007
Medical treatment of endocarditisElias Abrutyn, Christopher H Cabell, Vance G Fowler, et al.
International Journal of Antimicrobial Agents|February 5, 2019
Ceftaroline fosamil therapy in patients with acute bacterial skin and skin-structure infections with systemic inflammatory signs: A retrospective dose comparison across three pivotal trialsG Ralph Corey, Mark H Wilcox, Jesus Gonzalez, et al.
Diagnostic Microbiology and Infectious Disease|November 7, 2017
The effect of pulmonary surfactant on the in vitro activity of Iclaprim against common respiratory bacterial pathogensDavid B Huang, Leonard R Duncan, Robert K Flamm, et al.
American Heart Journal|May 17, 2011
Chronic noncommunicable cardiovascular and pulmonary disease in sub-Saharan Africa: an academic model for countering the epidemicGerald S Bloomfield, Sylvester Kimaiyo, E Jane Carter, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 11, 2010
Integrated analysis of CANVAS 1 and 2: phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infectionG Ralph Corey, Mark Wilcox, George H Talbot, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|March 2, 2010
Daptomycin compared to standard therapy for the treatment of native valve endocarditisZeina Kanafani, Helen Boucher, Vance Fowler, et al.
Antimicrobial Agents and Chemotherapy|June 3, 2009
Inoculum effect with cefazolin among clinical isolates of methicillin-susceptible Staphylococcus aureus: frequency and possible cause of cefazolin treatment failureEsteban C Nannini, Martin E Stryjewski, Kavindra V Singh, et al.
Pageof 16

Showing results (61-70 of 154) with videos related to

Sort By:
Pageof 16
Antimicrobial Agents and Chemotherapy|March 10, 2010
Determination of an inoculum effect with various cephalosporins among clinical isolates of methicillin-susceptible Staphylococcus aureusEsteban C Nannini, Martin E Stryjewski, Kavindra V Singh, et al.
Perioperative Medicine (London, England)|June 18, 2016
A randomized, double-blind, placebo controlled safety, tolerability, and pharmacokinetic dose escalation study of a gentamicin vancomycin gel in patients undergoing colorectal surgeryElliott Bennett-Guerrero, Harold S Minkowitz, Alvaro M Segura-Vasi, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|February 6, 2007
Correlation between fundamental binding forces and clinical prognosis of Staphylococcus aureus infections of medical implantsRuchirej Yongsunthon, Vance G Fowler, Brian H Lower, et al.
Current Infectious Disease Reports|July 10, 2007
Medical treatment of endocarditisElias Abrutyn, Christopher H Cabell, Vance G Fowler, et al.
International Journal of Antimicrobial Agents|February 5, 2019
Ceftaroline fosamil therapy in patients with acute bacterial skin and skin-structure infections with systemic inflammatory signs: A retrospective dose comparison across three pivotal trialsG Ralph Corey, Mark H Wilcox, Jesus Gonzalez, et al.
Diagnostic Microbiology and Infectious Disease|November 7, 2017
The effect of pulmonary surfactant on the in vitro activity of Iclaprim against common respiratory bacterial pathogensDavid B Huang, Leonard R Duncan, Robert K Flamm, et al.
American Heart Journal|May 17, 2011
Chronic noncommunicable cardiovascular and pulmonary disease in sub-Saharan Africa: an academic model for countering the epidemicGerald S Bloomfield, Sylvester Kimaiyo, E Jane Carter, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 11, 2010
Integrated analysis of CANVAS 1 and 2: phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infectionG Ralph Corey, Mark Wilcox, George H Talbot, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|March 2, 2010
Daptomycin compared to standard therapy for the treatment of native valve endocarditisZeina Kanafani, Helen Boucher, Vance Fowler, et al.
Antimicrobial Agents and Chemotherapy|June 3, 2009
Inoculum effect with cefazolin among clinical isolates of methicillin-susceptible Staphylococcus aureus: frequency and possible cause of cefazolin treatment failureEsteban C Nannini, Martin E Stryjewski, Kavindra V Singh, et al.
Pageof 16